Form 8-K - Current report:
SEC Accession No. 0000950170-25-103504
Filing Date
2025-08-06
Accepted
2025-08-06 06:30:26
Documents
10
Period of Report
2025-08-06
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K evok-20250806.htm   iXBRL 8-K 42670
  Complete submission text file 0000950170-25-103504.txt   144953

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20250806.xsd EX-101.SCH 23903
12 EXTRACTED XBRL INSTANCE DOCUMENT evok-20250806_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)